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A b s t r a c t  
The purpose of the present research was to evaluate the ability of ethosomes for topical delivery of 
isotretinoin. The ethosomal vesicles were prepared with various concentrations of lecithin and 
ethanol by using hot method. The ethosomal based isotretinoin gel (GEL-ES) was compared to that 
of marketed formulations isotretinoin (GEL-MF) by using hydrophobic hydroxyl propyl methyl 
cellulose as gel base. The physicochemical and stability of ethosomal based isotretinoin and a 
marketed gel (control) were evaluated for organoleptic properties, drug entrapment, drug content 
uniformity and in vitro drug release and skin permeation studies. F2 ethosomal vesicles containing 
2%w/w lecithin and 30%w/w ethanol was found to have shown the best entrapment percentage 
(99.21%) and also showed suitable physicochemical characteristics for topical administration. 
Physical stability studies were also conducted for 45 days at 4ĈC and 25ĈC. GEL-ES and GEL-MF 
were applied to rat skin and penetration was assessed by Franz diffusion cells. In vitro release 
studies showed that less than 10% of isotretinoin reached the receptor compartment compared to 
GEL-MF till 8 h. On comparing F2 and F4 gel formulations, F2 gel has shown better controlled 
release by in vitro drug release and in vitro skin permeation profile than F4 gel. However, the in vitro 
skin permeation was increased with the addition of enhancers. From the experimental data, it may 
be concluded that the ethosomal vesicles and enhancers increased the skin permeation and depot 
formation of drug in the skin. 
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Introduction 
 Isotretinoin, a derivative of retinoic acid (13-cis-retinoic acid), has 
been commonly used for the treatment of severe acne and the 
other dermatological diseases [1]. However, it has obvious adverse 
side effects by oral administration. The launched topical 
preparations such as creams and gels also show systemic 
absorption and significant skin irritation [2].  So, it is necessary to 
improve the skin uptake and reduce systemic absorption of 
isotretinoin using a carrier with an ability of skin targeting. 
According to Zouboulis [3], topical retinoids alone or in 
combinations are regarded as first-line treatment for both 
comedogenic and mild inflammatory acne [4]. It is believed that 
topical isotretinoin has similar properties as oral isotretinoin. 
However, the application of topical isotretinoin is associated with 
the problems of photolability and low solubility. There is substantial 
degradation of drug on the skin surface due to photolability [5]. 
Isotretinoin is highly lipophilic drug, hence, could not penetrates 
into deep skin layers.  
Ethosomes are designed as non-invasive drug carrier system [6]. 
Touitou (1996) had discovered that ethosomes are lipid vesicular 
systems embodying ethanol in relatively high concentration [7]. 
They are soft and malleable vesicles. High concentration of ethanol 
in ethosomes formulation was suggested to be the main reason for 
their better skin permeation ability compared to conventional 
liposomes [8]. Touitou et al, reported that ethanol acts as a 
penetration enhancer in ethosomal system. It penetrates into 
intercellular lipids, in turn increases the lipid fluidity and decrease 
the density of lipid multilayer of cell membrane [8]. Increased lipid 
fluidity results in increased skin permeability. Therefore, ethosomes 
permeate easily into the deep skin layers, where it is fused with 
skin lipids, leading to release of drug in deep skin layers [8].  
Ethosomes vesicles are preferred as a carrier of isotretinoin due to 
the absence of ethanol in liposomes. Besides, ethosomes are more 
permeable to cations as compared to liposomes [6]. Ethosomal 
vesicles have more benefits in comparison to other transdermal 
delivery systems [8]. Ethosomal vesicles enhance drug permeation 
through the skin and may deliver large molecules of compounds 
[9]. Chemical enhancers which are being used in the research are 
eugenol or N-methyl-2-pyrrolidone. Generally, chemical enhancers 
act to enhance permeation of drug through the skin. These 
enhancers mainly disrupt the structure of stratum corneum lipid, 
interact with intercellular protein and improve drug partitioning into 
stratum corneum [10]. The present study was aimed to evaluate 
the potential of the ethosomes for topical delivery of isotretinoin, 
the physiochemical properties of the ethosomes vesicles, and the 
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in vitro drug release and skin permeation behaviour of the 
ethosomal gel formulation with or without enhancers. 
Material and Methods  
Materials 
Isotretinoin was purchased from Yang Zhou Kai Peng, china. Soy 
lecithin (Lipamin PC 50) was purchased from Lecico, Hamburg, 
Germany. 1,2-Propanediol (Empura®) was purchased from Merck, 
Hohenbrunn, Germany. Pharmasolve was purchased from ISP 
Technologies, Inc., Alps Road Wayne, NJ, USA. Eugenol was 
purchased from Spectrum Chemical MFG, Corp., Gardena, New 
Brunwick, NJ, USA. Sangelose 60L and Sangelose 90L were 
kindly gifted from Daido, Japan.  
Preparation of ethosomal vesicles  
Isotretinoin ethosomal formulations were prepared by „Hot Method‰ 
[11]. The drug concentration was fixed as 0.05% w/w. The soy 
lecithin (phospholipid) and ethanol concentration was in the range 
of 1- 4% w/w and 20-40% w/w respectively. Accurately weighed 
quantity of drug was dissolved in ethanol and propylene glycol was 
added to it. The soy lecithin was dissolved in water at 40ĈC in 
another beaker. The drug solution was then added slowly to soy 
lecithin dispersion of water at 40ĈC with 1,700 rpm in a closed 
vessel and was stirred for 30 minutes. The final preparation was 
subjected to ultra-sonication for an hour with a cycle of 10 minutes. 
The evenly dispersed ethosomal vesicle was formed. The 
composition of ethosomal vesicles are shown in the Table 1.  
Preparation of isotretinoin ethosomal gel  
The isotretinoin ethosomal vesicles with the best entrapment 
efficiency result, F2 and F4 were chosen for gel formulation. A 
specific amount of Sangelose 60L was added in minimum amount 
of water and left to swell for an hour. An appropriate amount of F2 
or F4 was incorporated to the swollen Sangelose with continuous 
stirring at 700 rpm and the temperature was maintained at 30ĈC 
until homogenous ethosomal gel was formed. pH of the gel was 
then adjusted by adding small amount of triethanolamine (TEA) 
and stirred slowly. Final gel formulation was subjected to 
ultrasonication [12].  
Organoleptic properties  
The colour, texture, physical appearance and homogeneity of the 
gels were evaluated by visual observations [13].  
Particle size analysis of ethosomes  
Particle   size was   measured using the laser dynamic scattering 
Mastersizer 3000 (Malvern, England) immediately after diluting the 
ethosomes with phosphate buffer saline solution. The average 
particle size of ethosomes was calculated based on the 
measurements of 5 batches of ethosomes.  
Drug content and uniformity  
An aliquot of gel (0.1g) was extracted with 10ml of methanol and 
then centrifuged with 1,000 rpm at 4ĈC for 20 minutes. The 
supernatant obtained was analysed by using HPLC [14]. 
Drug entrapment efficiency  
The ability of ethosomes to efficiently entrap drugs was measured 
by centrifugation technique [14]. The vesicles (2ml) were 
centrifuged at 4ĈC with 14,000 rpm for 3 hours. The supernatant 
and sediment obtained were then analysed for drug content using 
HPLC. The entrapment efficiency was calculated by the following 
equation.  
Entrapment Efficiency (%) = (D/DT) x 100%  
Where, D = Amount of drug in sediment  
DT = Total amount of drug in supernatant and sediment  
PH measurements  
The pH of ethosomal formulations was measured by using the pH 
meter. The electrode was dipped into the vesicles as long as 
covered by the vesicles.  
Stability study  
The stability of ethosomal vesicles were determined by identifying 
the change in drug entrapment efficiency. The vesicles were stored 
in two different temperatures, 4ĈC and 25ĈCμ2ĈC. Then, the drug 
content of the vesicles was estimated every 15 days for 45 days. 
In vitro drug release study  
In vitro drug release study of drug in ethosomes was carried out by 
using Franz diffusion cell. A specified amount of gel formulation 
was applied on the cellulose acetate membrane at the donor 
compartment. The receptor compartment was filled with PBS:THF 
(50:50) as receptor solution. Sample solution (0.5mL) was 
withdrawn at 1 hour interval for 8 hours and immediately replaced 
with the same volume of receptor solution. The samples were then 
analyzed by using HPLC [15].  
In vitro skin permeation study  
A section of freshly excised rat skin was immersed in isotonic 
solution (0.9g sodium chloride dissolved in 100mL of R.O water). 
Ethosomal vesicles and gel were on rat skin and placed on top of 
the donor compartment of Franz diffusion cell. The dermal side of 
the skin must just touch the receptor liquid surface for permeation. 
All other analysis conditions were similar to the in vitro release 
study [15]. And skin retention of dug was analyzed by HPLC 
method [16]. 
HPLC Assay 
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Isotretinoin was estimated in skin deposition study by the HPLC 
method as reported by Tashtoush et al. [17].  Trifluoroacetic acid 
(0.01%) and acetonitrile (15: 85 v/v%) was used as mobile phase 
and delivered at 1.0 mL mină1. The injected fluid (20 μL) was 
eluted in C 18 column at room temperature and isotretinoin was 
monitored at 341 nm using a UV detector. The calibration curve 
with in a concentration range from 0.5 to 10.0 μg/mL was used to 
measure the isotretinoin concentration. The relative standard 
deviation around the calibration line ranged from 1.0% to 4.5% and 
the squared correlation coefficient was 0.9972. 
Statistical analysis  
The results are presented as mean μ standard deviation. One-way 
analysis of variance (ANOVA) was used to analyze the 
experimental data collected. Post-hoc Tukey-HSD (Honestly 
Significant Difference) test was performed if statistically significant 
difference was obtained. A statistically significant difference was 
considered at p < 0.05. 
 
Results and Discussion  
Physicochemical properties of ethosomal gel  
The results of physicochemical properties of gel formulations are 
shown in Table 1 and 2. All the gel formulations, including the 
marketed formulations, were in yellow colour, transparent in nature, 
have good homogeneity and smooth texture. The impact of 
different concentrations of phospholipids as well as ethanol such 
as 1.0, 2.0, 3.0% and 20, 30, 40% respectively on the entrapment 
efficiency of ethosomes was evaluated.  
Results showed that both the particle size of ethosomes and the 
entrapment efficiency of isotretinoin ethosomes increased with the 
increasing concentration of phospholipids, whereas decrease with 
increasing percentages of ethanol (Table 1). As a vesicle-
structured neotype of drug carrier, ethosome has the 
characteristics of good deformability, high entrapment efficiency, 
good   permeability and    good stability, which enable them to 
effectively carry the drug through the skin, and to penetrate through 
cuticle to get into deeper layers. It was the good fluidity and 
deformability given by ethanol that enabled ethosomes to carry 
drug to penetrate through the eyelet, 1/5 to 1/10 less than its size 
without much change in shape under the pressure of hydration, so 
as to penetrate through cell membrane and release drug more 
effectively than liposomes [18]. Generally, ethosome comprises of 
high concentration of low molecular weight alcohol (ethanol, 
propylene glycol, and isopropyl alcohol), phospholipid and water, 
and sometimes the addition of cholesterol [19].  
 
 Table 1: Composition of various ethosomal vesicles. 
Batch  
No 
Composition (% w/w) in 100mL Vesicle 
Size  
(øm) 
EE  
(%) Drug 
(%w/w) 
Lecithin
(%w/w) 
Ethanol
(%w/w) 
Propylene 
Glycol (%w/w) 
Wate
r 
F0 0.05 1 20 20 q.s. 3.46 94.78 
F1 0.05 2 20 20 q.s. 3.58 98.06 
F2 0.05 3 20 20 q.s. 3.64 99.21 
F3 0.05 1 30 20 q.s. 2.46 97.63 
F4 0.05 2 30 20 q.s. 2.60 98.59 
F5 0.05 3 30 20 q.s. 2.80 98.15 
F6 0.05 1 40 20 q.s. 1.96 89.57 
F7 0.05 2 40 20 q.s. 2.10 93.43 
F8 0.05 3 40 20 q.s. 2.24 92.73 
 
Impact of phospholipid and ethanol concentration on 
entrapment efficiency 
The size distribution of ethosomes ranged between about 200 nm 
to 360nm and is known to be influenced by the composition of 
ethosomes. Table 1 shows that the size of the vesicles decreased 
when the ethanol concentration was increased from 20% to 40%. 
The largest vesicles of 3.64 μ 18 nm size were present in the 
preparation containing 20% ethanol, while the smallest vesicles of 
1.96 μ 23 nm size were present in the preparation containing 40% 
ethanol.  This significant difference in the size of ethosomal 
formulations is because of the presence of different concentrations 
of ethanol. Probably, ethanol causes a modification in net charge of 
the system and confers it some degree of stearic stabilization that 
may lead to decrease in mean vesicle size. The composition of 
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different ethosomal formulations is summarized in Table 1. The 
entrapment efficiency for isotretinoin in optimized ethosomal 
formulation was 57.2% μ 2.5% (F2) and 41.4% μ 1.7% (F4), 
respectively. The higher entrapment efficiency of isotretinoin in 
ethosomes in comparison to marketed formulation was probably 
due to the presence of ethanol in vesicle membrane (18). 
Increasing the concentration of ethanol from 20% to 40% increased 
the entrapment efficiency owing to increase in fluidity of 
membranes. However, further increase in the ethanol 
concentration in the lower phospholipids formulations F6 (89.57%) 
probably made the vesicle membrane more leaky, thus leading to 
decrease in entrapment of lamivudine (Table 1). The range of drug 
entrapment efficiency of the isotretinoin ethosomal formulation was 
about 78.53% to 99.21%. F2 containing 2%w/w of phospholipid 
and 30%w/w of ethanol had maximum entrapment percentage of 
99.21% among ten ethosomal vesicles (Table 1). 
pH meter was used to measure the pH of ethosomal vesicles. The 
pH of the vesicles was fall within pH 4.0-5.0 (Figure 1). The result 
of pH revealed that the pH increases as the ethanol concentration 
increased when the lecithin concentration was constant. However, 
the pH decreases as the lecithin concentration increase when the 
ethanol concentration was constant. 
 
 
Table 2: Evaluation on the physicochemical properties of gel formulations 
Batch code Colour Physical 
Appearance 
Homogeneity Texture Spreadability 
(gm.mm/min) 
Drug 
Content (%) 
Marketed 
Formulations 
Yellow Transparent Homogenous Smooth 505 35.73 
F2 Yellow Transparent Homogenous Smooth 482.5 41.21 
F4 Yellow Transparent Homogenous Smooth 500 44.26 
 
Stability study  
The stability of ethosomal vesicles were identified by measuring 
the pH and drug entrapment efficiency at 0ĈC and 25ĈC from 0 to 
45 days. The figures 2 and 3 shows that the ethosomal vesicles 
had better drug entrapment efficiency by storing at 4ĈC than at 
25ĈC even at 45th days. Even in the case of pH also ethosomal 
formulations were more stable at 4ĈC than at 25ĈC that data and 
figures are not presented in this manuscript. Both the drug and 
concentration of ethanol influence the transition temperature of 
vesicular lipids. Storage stability of ethosomal systems can be 
determined by comparing the shape, average size and entrapment 
capacity of the vesicles over time at different storage conditions. 
 
 
Figure 1: Variation in pH of Isotretinoin ethosomal vesicles 
 
  
 
Figure 2: Drug entrapment efficiency of the vesicles from day 0 to 
day 45 at 4ĈC. 
 
Figure 3: Drug entrapment efficiency of the vesicles from day 0 to 
day 45 at 25ĈC. 
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Based on various stability studies performed, researchers suggest 
refrigerated condition (4- 8°C) as the suitable storage condition for 
ethosomal formulations. Higher temperatures may cause 
degradation of vesicular lipids loss of structural integrity of vesicles 
and an accelerated leakage of the entrapped contents. [20-21]. 
Loss of drug from the vesicles stored at elevated temperatures 
may be attributed to the effect of temperature on the gel to liquid 
transition of lipid bilayers together with possible chemical 
degradation of the phospholipids, leading to defects in membrane 
packing [22]. Lower percentage of drug leakage at higher 
temperatures, as observed in storage stability studies clearly 
showed that ethosomes are more stable in comparison with other 
vesicular delivery systems. The optimized gel formulation (F2 gel) 
was used in this study. As shown in figure 4, the drug content was 
more stable with F2 gel stored at 4ĈC than at 25ĈC.  
 
 
Figure 4: Comparison of Drug Content (%) between 4ĈC and 25ĈC. 
In vitro drug release study  
The drug release profile of marketed product showed significantly 
(p<0.05) better release compared to F4 and F2 gel as shown in 
Figure 5. Phosphate buffer saline of 7.4 is generally used as the 
receptor phase in release and skin permeation studies. Isotretinoin 
solubility in PBS is very low (1.8 μ 0.4 μg/ml) and could not provide 
the perfect sink condition. In such a condition, an co-solvents or 
solubilizers becomes essential. To find a suitable receptor liquid, 
preliminary solubility study with isotretinoin using three receptor 
phases propylene glycol, Tween and tetrahydrofuran (1:20 PBS 6.8 
solutions (01:1) and PBS 7.4 alone. Results showed that the 
tetrahydrofuran solutions increase the solubility of isotretinoin and 
provide a perfect sink condition. Solubility of isotretinoin in this 
receptor phase was found 58.1μ4.2 μg/ml.  
The percentage cumulative release after 8 h from different 
formulations of ethosome shown in figure 5. The cumulative 
release of drug on a percentage basis from F2, F4 and MF was 
plotted against the square root of time (tó) in Figure 5. From the 
plots presented it is clear that the release of the drug from the 
ethosome vesicles followed the diffusion controlled model in which 
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Figure 5: Comparison of in vitro drug release profile of various gel 
formulations. 
the total percentage of drug released is proportional to the square 
root of time.  The drug release profile of marketed product showed 
significantly (p<0.05) higher percent release (30%) compared to F2 
and F4 gel. In comparison between F2 and F4 gel, the total release 
after eight hours from F2 gel (45.11 %) was more than two times 
the total release after eight hours shown by F4 gel (62%). The 
main reason is that the higher amount of ethanol concentration of 
batch F4 (30%), increase the vehicle movement more freely 
through the membrane. On comparing the release kinetics data 
(Table 3), F2 and F4 gel were found to release the drug in 
accordance to Higuchi Kinetics which were indicated by the highest 
correlation coefficient values. 
 
Table 3: Release Rate Constant (k) and correlation coefficient (R2) 
of gel formulations 
Gel 
Formulations 
  
Zero Order  
Kinetics 
First Order 
Kinetics 
Higuchi 
Kinetics 
k R2 k R2 k R2
Marketed 
Formulations 2.568 0.951 1.842 0.951 0.412 0.901 
F2 gel 3.759 0.7989 1.983 0.813 0.986 0.973 
F4 gel 1.444 0.961 1.995 0.958 0.307 0.985 
In vitro skin permeation study  
After review of all the factors including physiochemical properties, 
release pattern, entrapment efficiency before and after storage, the 
ethosome F2 batch and MF were selected for skin permeation 
studies. Each selected formulation was evaluated using the rat skin 
model, and the average of three determinations reported. 
Generally the in vitro drug release and skin permeation studies 
showed that the skin is the rate-limiting factor because the in vitro 
release of the drug was greater from each the formulations 
compared with the respective in vitro drug permeation rate. To 
overcome this stratum corneum barrier we have added two 
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different chemical enhancers in F2 batch such as N-methyl-2-
pyrrolidone (NMP) and eugenol (Eu).   
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Figure 6: In vitro skin permeation profile of F2 gel without or with 
enhancers. 
 
On comparing the permeation profiles of isotretinoin with and 
without enhancers gels formulation (F2, F2-NMP and F2-Eu) to 
marketed product (MF) (Figure 6), the permeation profile of 
marketed formulation showed significantly amount (p<0.05) 
permeated (26%) through the skin into the receptor compartment.  
Whereas ethosomal gel (F2 ă 9.2%) with chemical enhancers both 
F2- NMP (13%) and F2-Eu (16%) formulations permeated into the 
receptor medium respectively up to 8 hours. It may be due to 
presence of ethanol in ethosomal gels which furnishes the vesicles 
with a flexibility that allows them to penetrate into deep skin layers 
more easily [25]. Also phospholipids are hygroscopic in nature and 
bind easily with water. For this reason we assume that this property 
increases the skin humidity and that leads to maximal hydration of 
the horny layer. In addition any residual ethanol would be 
synergistic with the phospholipds [24]. The cumulative drug 
permeation as a percentage from different formulations was plotted 
against the permeation time in hours (t) in Figure 6. In each plot, 
the rate of drug permeation is fairly constant over time and the 
permeation profiles exhibit the concentration dependent first-order 
kinetics. Skin deposition study was carried out with the objective to 
determine the percent deposition effect of ethosome in the deeper 
layer of skin. For an effective anti-acne agent, it must deliver the 
drug to deeper layers of skin. Figure 7 shows that the percent skin 
deposition of isotretinoin ethosomal gels with and without 
enhancers and marketed formulation. The amount of drug 
deposited was 15-folds higher in case of ethosomal gel (F2).  
Skin deposition study showed that the F2 batch gel showed better 
deposition and skin-targeting effect of ethosomal formulation, may 
be due to ethosomal vesicle is too large to enter into the deeper 
skin tissue directly; this kind of action could help the isotretinion 
bypass the cutaneous capillary circulation and hence they may act 
as depot and sustain the drug release locally. In the case of 
enhancers containing gels, depot formation is lower due to these 
enhancers as well as higher amount of ethanol may potentiate the 
skin lipid hydrolysis and leads to increase drug permeation across 
the skin and reached into the receptor medium. 
 
Figure 7: In vitro skin deposition profile of different formaulations. 
 
Whereas the marketed formulation does not have the vesicles 
system unlike ethosome that may be the reason this formulation 
also reached into the receptor medium without formation of depot 
drug delivery. This kind of release pattern from F2 ăEu and MF 
allows the drug intradermal capillary and once it reaches into the 
dermis region of the skin and then it will reach the systemic 
circulation [23]. 
Conclusion 
The presence of ethanol in ethosomes plays an important role in 
permeation of the isotretinoin through the upper layer of the skin. 
Phospholipids may increase the drug absorption and retain the 
drug in the skin tissues for longer periods as shown in the 
experimental findings. The enhancers incorporated in the 
ethosomal gel also increase the drug permeation through the skin. 
However, the result was insignificant. Based on the physiologic 
barrier and limitations in reaching effective component to the lesion 
areas, this study introduces a new method for the preparation of 
ethosome with lecithin, ethanol and water, which has advantages 
of even distribution of particles and its vesicles with high 
entrapment efficiency. Further experimental studies need to be 
carried out to find out lecithin distribution behavior in the skin 
tissues. The clinical efficacy of a topically applied drug depends not 
only on pharmacological properties but also on the availability of 
drug at target site. However, F2 and F2-NMP formulation may 
avoid systemic circulation, photo stability problem and hence 
reduce the skin irritation and oral formulation relation side effects.  
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